Back to Results
Meet Carey D. Kimmelstiel, MD
Director, Interventional Cardiology Center; Professor, Tufts University School of Medicine
Department + Services
Medicine, CardioVascular Center, Cardiology
Clinical Focus Areas
Research Focus Areas
Adjunctive therapy for percutaneous coronary intervention , structural heart disease, septal ablation for hypertrophic cardiomyopathy
highest volume of Patient Foremen Ovale (PFO) Closures in the RESPECT Trial
Seeing Patients In
Programs + Specialties
Training + Education
State University of New York Downstate College of Medicine; University of Massachusetts Medical Center; Tufts Medical Center; Kings County Hospital/Downstate Medical Center
Internal Medicine, Cardiovascular Disease, Interventional Cardiology
View Accepted Insurances at Tufts MC + Tufts Children's Hospital
Locations + Directions
Tufts Medical Center
South Building, 6th Floor
860 Washington St.
Boston, MA 02111
Phone #: 617-636-2273
Fax #: 617-636-5913
Honors + Awards
2021, "Top Doctor", Boston Magazine
2020, "Top Doctor," Boston Magazine
2018/2019, "Top Doctor," Boston Magazine
2015, "Top Doctor," Boston Magazine
2013, "Top Doctor," Boston Magazine
2012, "Top Doctor," Boston Magazine
2012, "Top Doctor," U.S. News & World Report
Biology Honor Award
Summa Cum Laude
Oliver Smith Award for Excellence in Patient Care
Publications + National Presentations
1. Kimmelstiel C, Phang R, Rehman A, et al. Outcomes following the use of different GP IIb/IIIa antagonists in patients undergoing coronary intervention. J Thrombos and Thrombolys 2001;11:203-9.
2. Kimmelstiel CD, Maron BJ. Percutaneous septal ablation in hypertrophic cardiomyopathy. Circulation 2004; 109:452-56.
3. Kimmelstiel C, Levine D, Perry K, et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: The SPAN-CHF Trial. Circulation 2004;110:1450-55.
4. Kimmelstiel C, Badar J, Covic L, et al. Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage. Thromb Res 2005;116:55-66.
5. Kimmelstiel C, Gange C, Thaler DE. Is PFO Closure effective in reducing migraine symptoms? A controlled study. Cath Cardiovasc Intervent 2007; 69:740–46.
Fellow, American College of Cardiology
Fellow, American College of Physicians
Fellow, Society for Cardiac Angiography and Interventions
American Heart Association
AHA Council on Clinical Cardiology
Massachusetts Medical Society
News, Media + Videos